Cohlhepp Ryan

Insider·Bicara Therapeutics Inc.·BCAX·Insider since 2025·Form 4 filings: 13
Trades YTD
3
Trades (12m)
13
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

13 transactions
22 Jan 2026
SOLD
$BCAX
3,828
$18.10
S
22 Jan 2026
SOLD
$BCAX
3,828
$18.10
S
15 Jan 2026
SOLD
$BCAX
149
$18.02
S
15 Dec 2025
SOLD
$BCAX
4,500
$18.68
S
15 Dec 2025
SOLD
$BCAX
8,000
$18.68
S
21 Nov 2025
SOLD
$BCAX
4,500
$18.05
S
21 Nov 2025
SOLD
$BCAX
8,000
$18.05
S
15 Oct 2025
SOLD
$BCAX
4,500
$18.16
S
15 Oct 2025
SOLD
$BCAX
8,000
$18.16
S
07 Oct 2025
SOLD
$BCAX
2,900
$18.06
S
07 Oct 2025
SOLD
$BCAX
8,000
$18.06
S
06 Oct 2025
SOLD
$BCAX
15,600
$18.06
S
06 Oct 2025
SOLD
$BCAX
24,000
$18.06
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Bicara Therapeutics Inc.

last 30 days

No active insider cluster at Bicara Therapeutics Inc. in the last 30 days. Ryan's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Ryan is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 10:36 UTC.